A panel of four biomarkers (TNF-α, Insulin, AGEs and creatinine) might be used for early detection of DCM (DM-DD) among T2DM patients with sensitivity of approximately 79% and specificity of 100%. This evidence concerns the gene INS and familial dilated cardiomyopathy.